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Design of a regulatable multistate protein is a challenge for protein
engineering. Here we design a protein with a unique topology,
called uniRapR, whose conformation is controlled by the binding
of a small molecule. We confirm switching and control ability of
uniRapR in silico, in vitro, and in vivo. As a proof of concept, uniRapR
is used as an artificial regulatory domain to control activity of
kinases. By activating Src kinase using uniRapR in single cells and
whole organism, we observe two unique phenotypes consistent
with its role in metastasis. Activation of Src kinase leads to rapid
induction of protrusion with polarized spreading in HeLa cells, and
morphological changes with loss of cell–cell contacts in the epider-
mal tissue of zebrafish. The rational creation of uniRapR exemplifies
the strength of computational protein design, and offers a powerful
means for targeted activation of many pathways to study signaling
in living organisms.
spatiotemporal control | cell motility | endothelial-mesenchymal transition
The past two decades have seen a revolution in computationalprotein design, with remarkable milestones including design
of a helical protein from first principles (1), redesign of zinc
finger proteins (2), and de novo design of an α/β protein (3). These
studies highlighted, as a proof of principle, our ability to rationally
control the structure of proteins by using basic physical principles
and phenomenology. These approaches are based on finding an
optimal sequence for a given single structure or ensemble of re-
lated states, and do not provide a strategy to construct a protein
capable of large on-demand conformational transitions (4, 5).
A number of multistate protein design algorithms (4, 6) have been
proposed; however, designing an experimentally confirmed, reg-
ulatable multistate protein, or a conformational switch (5), still
remains as a challenging task because of the necessity of engi-
neering and controlling multiple protein states (4, 7, 8).
Such a conformational switch protein has great advantages in
cell signaling, because it can be used as a universal regulatory
domain (9) for precise, specific, and temporal control over rap-
idly activated signaling proteins (5, 10–15). Traditional geneti-
cally encoded methods for temporal protein control at the
protein level have several drawbacks (5, 13). Recently developed
protein switches, including derivatives of the light, oxygen, or
voltage (LOV) domain (16, 17), can provide direct control at the
protein level with light, but cannot be readily used in non-
transparent animals. Our previous rapamycin regulated (RapR)
kinase method (14) can potentially overcome this problem, but it
requires expression and control of two proteins. The variable
stoichiometry of these proteins renders the response more het-
erogeneous and essentially impractical in animals. Therefore,
a single-chain, insertable, and transferable regulatory domain
would be very valuable.
Here we design a ligand-controlled conformational switch,
uniRapR, a potentially broadly applicable, single-chain regu-
latory domain. We first confirm its switching properties and
control ability with molecular dynamics and in vitro enzymatic
assays. Further, by temporally activating Src kinase with uniRapR
in living single cells and zebrafish, we reveal two phenotypes
related to the role of this kinase in metastasis.
Results
Design of uniRapR with Desired Stability and Conformational Dynamics.
Design of ligand binding proteins is still an unsolved problem in
protein design (18); therefore, to design a ligand-controlled pro-
tein, we first use the binding pocket of one of the highest-affinity
(19) protein–ligand complexes, 12-kDa FK506-binding protein
(FKBP12) and FKBP12-rapamycin binding protein (FRB) in
complex with rapamycin (20). We rationally rewired this complex
to build a single-chain protein featuring a unique topology (21)
(Fig. 1A and Fig. S1). To construct the subdomain-A of uniRapR,
we used elements of insertable FKBP12 (iFKBP), a modified
FKBP; we previously demonstrated that its insertion does not de-
stroy the structure of a host protein (14). Subdomain-B of uni-
RapR contains the rapamycin-binding surface of FRB, and we
stabilized this surface with two helices grafted from FRB. Thus, we
expect the resulting design has all the desired properties of a uni-
versal regulatory domain featuring modularity, transferability, and
robust switching ability.
To test conformational switching features of uniRapR, we
constructed a structural model of uniRapR based on complex
structure of FKBP-FRB–rapamycin and performed replica ex-
change and equilibrium discrete molecular dynamics (DMD)
simulations (22, 23) (Fig. 1B and Materials and Methods). Pre-
vious studies that used insertable FKBP showed that the tran-
sition between a folded and unfolded state could be used to
control kinase activity when the FKBP was inserted at a con-
served site in kinases. Therefore, desired switching properties of
uniRapR were achieved by manipulating the subdomain motions
and changing the relative stability between the folded and un-
folded states. We estimated the stability of uniRapR states by
characterizing its folding thermodynamics. We calculated its
specific heat and the root-mean-square deviations (rmsds) from
the native structure of iFKBP as a function of temperature. A
peak in the specific heat curve corresponds to the folding tran-
sition, indicated by significant increase of rmsd (Fig. 1 C and D).
We observed the stabilization of uniRapR upon rapamycin
binding as a shift of the peak of the specific heat curve to a higher
temperature. UniRapR can achieve regulatory function when
inserted into a host kinase because its thermal stability and
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a change in its equilibrium amino- (N-) and carboxy- (C-)
termini distance are dependent on rapamycin binding. Indeed,
we observed reduced distance between Cα atoms of N- and C-
termini upon binding of rapamycin (Fig. 1E). Equilibrium simu-
lations confirmed that subdomain-A only interacts with sub-
domain-B in the presence of rapamycin (Fig. 1F and Movies S1
and S2). These observations suggest that the conformation of
uniRapR depends on the presence of rapamycin, whereby binding
of rapamycin to the pocket formed by the two subdomains
stabilizes uniRapR.
Change in ATP Binding Site Dynamics Confer Allosteric Control in Src
Kinase. We hypothesize that uniRapR renders a protein switch-
able when inserted into a site that is allosterically coupled to its
active site. Allosteric sites can be identified by using information
from experimental mutation studies in the literature or by using
various computational methods (24–26). We inserted uniRapR
into the Src kinase at a site known (14) to be allosterically coupled
to the ATP binding site (Fig. 2). In equilibrium DMD simulations,
we observed that uniRapR inserted into Src at residue 288 with
optimized double-gly-pro-gly (GPG) linkers destabilized the ATP
binding site through long-range interactions, suggesting inactiva-
tion of the kinase in the absence of rapamycin. Rapamycin binding
to uniRapR reduced fluctuations in the G-loop (residues 276–279),
which is part of the ATP binding site. The reduced fluctuations in
the presence of rapamycin restored the G-loop dynamics of Src-
uniRapR to a level identical to that of WT Src (Fig. 2B), implying
activation of the kinase in the presence of rapamycin. Computa-
tional analysis thus suggests that Src kinase activity can be regulated
by inserting uniRapR at a position that is allosterically coupled to
the ATP binding site.
UniRapR Allows Specific and Robust Control over Various Kinases in
Vitro. We tested uniRapR functionality in vitro by using Src ki-
nase expressed in HEK293T cells. By using paxillin and poly-
Glu-Tyr (E4Y) as the Src substrates, we observed that consti-
tutively active (YF) Src kinase (27) modified with uniRapR
[uniRapR Src (YF)] demonstrated greatly enhanced activity in
the presence of rapamycin, confirming that uniRapR functions
as a specific on/off switch (Fig. 2C and Figs. S2–S7). A catalyti-
cally dead Src mutant (D388R) (14) with inserted uniRapR was
inactive regardless of the presence of rapamycin, indicating that
rapamycin-induced phosphorylation of paxillin or E4Y is caused
by only Src-uniRapR catalytic activity (Fig. 2C and Fig. S7).
Additionally, when we constrained the hinge motion of the
uniRapR domain by substituting the optimized flexible linker
(Fig. S2) between subdomains with a rigid poly-proline linker
(uniRapR-L1P), catalytic activity in the presence of rapamycin
was abolished (Fig. 2D). Based on our model and on the crystal
structure of the FKBP12/FRB complex showing that Y271 [Y82
in the complex entered with Protein Data Bank ID code 1FAP]
is in contact with rapamycin, we expected Y271A substitution to
abolish rapamycin binding. We observed dramatically reduced
activity of uniRapR Src (Y271A), further indicating that uni-
RapR Src switching activity is directly dependent on rapamycin
binding to uniRapR Src (Fig. 2 D and E). Significantly, we ob-
served that uniRapR Src has much higher switchable kinase
activity than did our previous dimerization-based control of ki-
nase activity (i.e., RapR), in which kinase activity was regulated
by using coexpressed WT FRB and iFKBP (14) (Fig. 2D). These
results indicate that insertion of the uniRapR switch enables us to
robustly and specifically control Src kinase activity.
To assess the transferability of the uniRapR switch, we inserted
uniRapR into analogous sites of focal adhesion kinase (FAK) and
mitogen activated kinase p38. Insertion of uniRapR into a con-
stitutively active mutant (28) of FAK (YM) inhibited the activity
of FAK (YM) for its substrate paxillin; addition of rapamycin
rescued FAK activity (Fig. 3A). Addition of rapamycin did not
rescue kinase-dead FAK (YM/KD) activity, suggesting that rapa-
mycin-induced phosphorylation of paxillin is only due to FAK-
uniRapR activity. A design with a different circularly permuted
version of uniRapR (Fig. S8A) did not allow control of FAK ac-
tivity (Fig. S8B). Insertion of uniRapR into p38 kinase with the
same GPG linker abolished its activity, which could be restored by
the addition of rapamycin. Activity of WT p38 was unchanged in
the presence of rapamycin (Fig. 3B). Insertion of uniRapR into p38
with an optimized linker described in our previous study (14)
resulted in a higher activity in the presence of rapamycin. Indeed,
we observed activity similar to WT in the presence of rapamycin
(Fig. 3B), indicating that optimal regulation of the host protein can
be achieved by varying the connection linker. All these data suggest
Fig. 1. Design and thermodynamics of uniRapR domain. (A) The FKBP12
(blue)/FRB (green) complex was used to build the switch module (Fig. S1).
While keeping the sequence from β2 to β5 of iFKBP, we linked β5 of sub-
domain-A to the carboxyl-terminal α-helix (α4) of subdomain-B by using an
optimized GS linker to permit a hinge-like motion. Because the N terminus
of α1 is relatively close to the C terminus of α4, we linked these two helices
using a PPGPGSG linker. Sequences of helices α2 and α3 were kept as in WT
FRB, and α3 was linked to the C-terminal β-strand (β6) of subdomain A, as the
N terminus of β6 of FKBP is in the vicinity of the ternary complex interface.
(B) A model of the holo-uniRapR (blue, subdomain-A; green, subdomain-B)
protein was built based on the crystal structure of the FKBP12/FRB complex
(Protein Data Bank ID code 1FAP) by using DMD. (C) Heat capacities of apo
(red) and holo (black) forms of uniRapR were calculated by using WHAM
(38). (D) rmsd values of apo (red) and holo (black) forms of subdomain-A
were calculated for different temperatures by using WHAM. (E) Distance
between Cα atoms of amino and carboxyl termini as a function of temper-
ature for apo (red) and holo (black) forms of uniRapR. (F) Relative positions
of uniRapR subdomains compared with the FKBP12/FRB proteins in complex.
Distance between centers of masses of uniRapR subdomains A and B was
calculated by using multiple molecular dynamics trajectories. In the presence of
rapamycin (black), distance of centers of masses of uniRapR subdomains is ∼24
Å, close to that of FKBP12 and FRB complex (green). In the absence of rapa-
mycin (red), uniRapR subdomains move randomly, and they are not in contact.
























that uniRapR can be inserted as a transferable regulatory domain
in a wide variety of kinases.
Specific Activation of Src Kinase Leads to Polarized Spreading in
Single Cells. Signaling cascades containing Src kinase play impor-
tant roles in cell growth, proliferation, migration, and tumor in-
vasiveness (27). However, the specific roles of Src catalytic activity,
especially in cell migration, are unclear because of the limitations
of existing chemical and genetic methods, including limited tem-
poral control of activation or inactivation. For example, over-
expression of constitutively active Src prevents the observation of
events immediately following Src activation, as the cell compen-
sates for Src expression, probably with other Src kinase family
members, during gradual increase in expression level. Likewise,
blocking Src expression with RNA interference is also a slow
process. We overcome these limitations by using uniRapR Src
(YF), which can reach maximal stimulation in less than 3 min.
To observe the effect of Src activation on cell motility, we
expressed uniRapR Src (YF) in HeLa cells. In the absence of
rapamycin, we observed only peripheral ruffles near the cell
edge, a phenotype also seen in untransfected cells. After rapa-
mycin addition, we observed a statistically significant increase in
cell area for all cells examined, relative to those expressing cat-
alytically dead Src (YF/KD)-uniRapR (area increase of 30 ± 5%,
n = 8 cells; Fig. 3 C and D and Movies S3 and S4). Control cells
showed no statistically significant change (area change of 8 ±
6%, n = 8 cells). In a control study, rapamycin alone did not have
any effect on the phenotype of untransfected cells. Polarized
spreading of HeLa cells following Src activation supports a role
for Src in cell invasiveness.
Specific Activation of Src Kinase Causes Loss of Cell–Cell Contacts in
Zebrafish Epidermis. Although we observe a profound impact of
Src activation in cultured cells, it is crucial to determine whether
uniRapR Src (YF) enables Src activation to be studied in the
context of a multicellular organism. To study the role of Src
activation during development, we expressed uniRapR Src
(YF) in zebrafish embryos (Fig. 4A). Epidermal cells expressing
uniRapR Src (YF) demonstrated WT polygonal shape and
formed tight connections with no gapping in the absence of
rapamycin (Fig. 4B). When we activated uniRapR Src (YF) by
adding rapamycin, the epidermal cells had extended protrusions
and underwent significant morphological changes in 12 to 16 h.
These morphological changes caused the loss of cell–cell contacts
as cells became more rounded (Fig. 4C). In control experiments,
we did not observe morphological changes when cells expressing
uniRapR Src were treated only with vehicle (Fig. 4 D and E), or
when we expressed the catalytically dead uniRapR Src (YF/KD)
construct in zebrafish embryos in the presence of rapamycin (Fig.
4 F and G), demonstrating that the observed effects are caused
specifically by uniRapR Src activation by rapamycin. This dra-
matic phenotype of altered cell morphology upon Src activation
demonstrates the applicability of uniRapR in studying signaling
pathways in whole organisms.
Fig. 2. Control of Src kinase activity with uniRapR domain. (A) Schematic representation of activity control with the uniRapR domain. (B) Root mean square
fluctuations of the ATP binding site (gray structure) based on multiple equilibrium DMD simulations for WT Src (black), apo (red), and holo (green) uniRapR-
inserted Src (P < 0.01). (C) HEK293T cells expressing the Src-uniRapR-cerulean-myc construct were treated with different concentrations of rapamycin (0–
2 μM), and lysates were assayed for expression of the construct with Western blotting by using anti-GFP. The construct was pulled down with anti-myc and
mixed with the paxillin substrate in the presence of ATP for 10 min. Reaction suspensions were blotted and probed with anti-myc and anti–pY31-paxillin to
confirm binding and phosphorylation of the substrate, respectively. (D) As controls, constitutively active Src (YF) without the uniRapR domain, kinase dead
(YF/KD), Y271A and L1polyP Src mutants with the uniRapR domain, and our previous dimerization-based switch were tested. (E) Y271A and L1polyP sub-
stitutions shown on the Src-uniRapR model.
Fig. 3. Testing uniRapR in different kinases and effects of Src activation in
HeLa cells. Immunoprecipitation, in vitro FAK (A), and p38 (B) assays were
performed similarly as for Src kinase. (C) Change in cell area of HeLa cells
expressing Src (YF)-uniRapR (n = 8/8 cells) or Src (YF/KD)-uniRapR (n = 8/8
cells). (D) HeLa cells expressing Src-uniRapR (YF)-cerulean demonstrate
spreading after the addition of rapamycin.
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Discussion
Design of a broadly applicable artificial regulatory domain has
been challenging for the following reasons: (i) the protein should
be able to adopt multiple states that can be ”switched” by ex-
ogenous stimulation, i.e., ligand binding; (ii) the designed switch
should be transferable, i.e., its action must be predictable and
reproducible in a variety of host proteins; and (iii) the protein
must be readily insertable into the host protein without signifi-
cantly destabilizing it. We have solved these problems by de-
signing a single-chain protein that can be regulated by a small
molecule. Control of activity via small-molecule binding can be
achieved by harnessing protein–protein interactions that occur in
the presence of ligands, for example type 2C protein phosphatase
ABI1/abscisic acid/PYR1-like (PYL1) (29) or FKBP12/rapamy-
cin/FRB (20). Here we use the FKBP12/rapamycin/FRB complex
because a photoactivable version of rapamycin is available, po-
tentially making uniRapR a tool for spatial as well as temporal
control of protein activity (30). Also, nonimmunosuppressive
rapamycin analogues (31), such as C-16-(S)-3-methylindoler-
apamycin (iRap), can be used for minimal perturbation of normal
physiology in animal studies. The iRap was proven to be in-
nocuous in living cells (32). Here we show that Src-uniRapR is
also active in the presence of iRap (Fig. S7). uniRapR can po-
tentially be applied to a wide range of rapidly activating, allosteric
signaling proteins. The dynamic behavior of a particular protein
in a signaling pathway can be investigated by using a uniRapR
protein analogue to activate the proteins with a resolution of
minutes. Moreover, by inserting uniRapR into putative allosteric
loops in a protein of interest, allosteric sites that are coupled can
be experimentally identified.
We selected Src kinase as a proof-of-concept system to be
tested in HeLa cells and zebrafish tissue because the specific role
of this Src family member in cell motility is unclear. The roles of
individual Src family members have proven to be difficult to
dissect by using traditional approaches because of the functional
redundancy and structural similarity of the Src family kinases
(SFKs). SFKs are involved in many cellular processes, including
transcription, differentiation, proliferation, development, motil-
ity, and cell death, and the majority of them have been identified
as cellular oncogenes (27, 33). By using a uniRapR version of
SFK members including Yes, Fyn, Lyn, Lck, Hck, Blk, Fgr, and
Yrk kinases, differential roles of these proteins in cell motility
can ultimately be elucidated.
An important advantage of uniRapR is its practical use in
animals. Light-dependent control can be useful at the single-cell
level, but uniRapR can provide activity control with the small
molecule rapamycin even within deep tissues, where light cannot
penetrate. To investigate the effect of Src kinase activation on
a higher-order process such as intercellular communication in
animals, a significant process involved in tissue development, re-
pair, immune response, and homeostasis (27, 33), we tested uni-
RapR Src in living zebrafish epidermal tissue. We demonstrated
that activation of Src kinase leads to a decrease in communication
between cells, consistent with its oncogenic role in metastasis. The
dynamic behavior of proteins downstream of Src, such as connexin
43 or Cas, that are involved in intercellular communication (34),
will be the subject of future study.
UniRapR is a unique example of an insertable, transferable,
and ligand-controllable protein switch. This switch has widespread
potential applications for understanding signaling pathways in-
volving kinases, a glimpse of which is offered by the unique phe-
notypes we demonstrate in mammalian cells and zebrafish tissue
upon Src kinase activation. The potentially wide applicability of
uniRapR is underscored by the structural conservation of kinases
and the allosteric properties of many signaling proteins.
Materials and Methods
Detailed experimental and computational procedures are presented in SI
Materials and Methods. In short: (i) DNA construction of the uniRapR do-
main and kinase-uniRapR constructs with all mutants was performed by
using QuikChange PCR (Table S1). (ii) Computational design, modeling, and
computational analysis of uniRapR and Src-uniRapR structures were performed
by using replica-exchange and equilibrium DMD simulations (35) and Medusa
modeling kit (36, 37) (Fig. S1 and Table S2). To analyze replica-exchange DMD
simulations, the weighted histogram analysis method (WHAM) (38) was used
to estimate thermodynamic properties of the uniRapR domain. (iii) Immuno-
precipitation and in vitro kinase assays were as performed previously described
(14). HEK293T cells expressing constructs were lysed, and protein constructs
were pulled down and tested with the paxillin and poly-Glu-Tyr (E4Y) as Src
and FAK substrate, and ATF2 as p38 substrate. The binding of the proteins to
antibody-conjugated beads and phosphorylation of substrates were confirmed
with Western Blotting. The enzymatic activities of immunoprecipitated con-
structs were determined by measuring the transfer rate of γ-32P from radio-
active ATP to substrate peptide E4Y. (iv) Live cell imaging was performed by
using HeLa cells with an Olympus IX-81 microscope equipped with a ZDC focus
drift compensator and a Photometrics CoolSnap ES2 CCD camera (Roper
Photometrics). (v) Imaging of live zebrafish embryo epidermis tissue was per-
formed with a confocal microscope (FluoView FV1000; Olympus).
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Fig. 4. Activation of Src induces cell changes in zebrafish epidermal cells.
(A) Synthetic transposase mRNA was coinjected with the Tol2 Krt4 Src (YF)-
uniRapR-cerulean plasmid into one-cell zebrafish embryos, resulting in mo-
saic expression of Src-uniRapR in the epidermis. Epidermal cells with char-
acteristic flat honeycomb morphology were selected and imaged before (B
and F) and after (C and G) 16 h of rapamycin treatment. (C) Epidermal cells
expressing Src (YF)-uniRapR-cerulean in zebrafish embryos exposed to 10 μM
rapamycin become rounded and undergo dynamic cell shape changes. White
arrows indicate an epidermal cell before and after each treatment. Control
epidermal cells expressing Src (YF)-uniRapR-cerulean in vehicle (i.e., DMSO)
(D and E) or expressing the kinase-dead construct Src (YF/KD)-uniRapR-
cerulean in rapamycin (G) have a static morphology and do not undergo
dynamic cell shape changes. (Scale bar: 30 μm.)
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